
51 - 200 employees
Founded 2018
🏥 Healthcare
💼 Consulting
🧬 Biotechnology
💰 $46M Series B on 2023-10
Healthcare • Consulting • Biotechnology
Angitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, focused on the discovery and development of breakthrough therapeutics for serious musculoskeletal diseases. With a strong emphasis on innovation, Angitia aims to address unmet medical needs through their pipeline of therapeutics, including treatments for conditions such as Osteogenesis Imperfecta and Osteoarthritis. The company is devoted to fostering a culture of respect and equality, and is committed to employee growth and career development while delivering effective therapies to help patients in need.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 2 hours ago
Global Regulatory Affairs Director leading regulatory strategies and submissions for Angitia’s clinical-stage musculoskeletal disease therapeutics. Guiding global health authority interactions and development programs.
🏄 California – Remote
💵 $180k - $230k / year
💰 $46M Series B on 2023-10
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 0%